1994
DOI: 10.1016/s0140-6736(94)90032-9
|View full text |Cite
|
Sign up to set email alerts
|

Therapeutic Immunisation against hellcobacter Infection

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

2
68
0
1

Year Published

1999
1999
2009
2009

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 138 publications
(71 citation statements)
references
References 3 publications
2
68
0
1
Order By: Relevance
“…Host responses are thought to contribute to the development of inflammation leading to gastritis or ulceration either by cross-reactive autoimmunity or bystander activation. Correspondingly, Th2-like patterns of immune response are protective against gastritis, and when induced by oral immunisation not only prevent but clear infection in mice [63]. Concurrent helminth infection also protects against the harmful consequences of H felis infection in mice [64].…”
Section: Other Co-evolutionary Candidatesmentioning
confidence: 99%
“…Host responses are thought to contribute to the development of inflammation leading to gastritis or ulceration either by cross-reactive autoimmunity or bystander activation. Correspondingly, Th2-like patterns of immune response are protective against gastritis, and when induced by oral immunisation not only prevent but clear infection in mice [63]. Concurrent helminth infection also protects against the harmful consequences of H felis infection in mice [64].…”
Section: Other Co-evolutionary Candidatesmentioning
confidence: 99%
“…104,127 These models have permitted the testing of prophylactic and therapeutic vaccines containing different antigens, including whole inactivated cells, 1 bacterial lysates, 128 and several purified antigens. To date, researchers have identified several H. pylori antigens which confer protection against H. pylori infection or in eradicating an already established infection in the murine models, including purified VacA, 104 urease (and its subunits), 129 CagA, 130 heat shock proteins (HspA and HspB), 1 and catalase.…”
Section: Vaccination Development For Clinical Use and Future Of The Hmentioning
confidence: 99%
“…137 Additionally, the use of non-toxic LTK63 or CT S61F for oral vaccination induces a relatively greater Th2 cell response that can cure and prevent infection in H. felis/ mice models. 128,129,135,139 Thus, with the discovery of the appropriate formulation and routes of administration, it is possible that vaccination could trigger an immune response that differs substantially from that induced by natural infection with H. pylori. Undoubtedly, the continuous efforts of laboratories around the world to develop a vaccine and therapeutic approaches may soon bring an end to the long evolutionary relationship between humankind and Helicobacter pylori.…”
Section: Vaccination Development For Clinical Use and Future Of The Hmentioning
confidence: 99%
“…Prophylactic or therapeutic vaccination against H. pylori is a desirable alternative to control the H. pylori infection (3), and animal studies have proven the feasibility of this approach (9,10,14,16,27,61).…”
mentioning
confidence: 99%